Abcellera’s patent involved in its collaboration with Gilead in infectious disease

SOPHIA-ANTIPOLIS, France – June 14, 2019: Abcellera’s patent involved in its collaboration with Gilead in infectious disease. AbCellera has announced a partnership with Gilead to discover antibodies for infectious disease. AbCellera will apply its expertise in single-cell screening of natural immune sources to generate rich panels of antibody candidates for evaluation by Gilead. Gilead is[…]

Applied Materials may enter the field of next-generation sequencing

SOPHIA-ANTIPOLIS, France – May 6, 2019: Nanopore sequencing is one of the next-generation sequencing (NGS) technologies believed to be capable of revolutionizing DNA analysis. Nanopore sequencing is performed using an electrical detection method, which generally includes transporting a sample through the nanopore, which is immersed in a conducting fluid, and applying electric potential across the[…]

Medical imaging technologies for OCT : a dynamic and competitive industry

Extracted from: Optical Coherence Tomography Medical Imaging – Patent Landscape report, Knowmade, February 2018 OUTLINES: • Recent mergers and acquisitions have occurred in the OCT medical imaging field. How will they impact the IP landscape? • OCT’s development began 25 years ago, under MIT’s impetus. • OCT medical imaging is a competitive market. Several products[…]

Microfluidics industry: what will trigger the next growth spurt?

“Microfluidic technologies have been around for a while, but only in the last few years have certain applications started benefiting from microfluidic breakthroughs”, comments Technology & Market Analyst, Sébastien Clerc from Yole Développement (Yole), part of Yole Group of Companies (1). Indeed, microfluidic technologies have finally found sweet spots and there are already credible options for[…]